How to Protect Yourself Against Malaria 1 4
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Psychiatric Side Effects of Mefloquine: Applications to Forensic Psychiatry
REGULAR ARTICLE Psychiatric Side Effects of Mefloquine: Applications to Forensic Psychiatry Elspeth Cameron Ritchie, MD, MPH, Jerald Block, MD, and Remington Lee Nevin, MD, MPH Mefloquine (previously marketed in the United States as Lariam®) is an antimalarial medication with potent psychotropic potential. Severe psychiatric side effects due to mefloquine intoxication are well documented, including anxiety, panic attacks, paranoia, persecutory delusions, dissociative psychosis, and anterograde amnesia. Exposure to the drug has been associated with acts of violence and suicide. In this article, we discuss the history of mefloquine use and describe plausible mechanisms of its psychotropic action. Mefloquine intoxication has not yet been successfully advanced in legal proceedings as a defense or as a mitigating factor, but it appears likely that it eventually will be. Considerations for the application of claims of mefloquine intoxication in forensic settings are discussed. J Am Acad Psychiatry Law 41:224–35, 2013 Mefloquine is a 4-quinolinemethanol antimalarial The company pursued regulatory approval and mar- first synthesized in the early 1970s1 by researchers keted the drug to civilian travelers in the United affiliated with the United States military’s Walter States under the trade name Lariam® after its initial Reed Army Institute of Research (WRAIR).2 The Food and Drug Administration (FDA) licensure in drug’s development was the culmination of a 10-year 1989.5 Owing to its efficacy, presumed safety, and drug discovery effort, during which time more than convenient dose schedule that facilitated prophylac- 300,000 compounds were screened for their antima- tic use, mefloquine was soon identified as the drug of 2 larial properties. -
Avian Malaria on Madagascar: Prevalence, Biodiversity and Specialization of Haemosporidian Parasites
International Journal for Parasitology 49 (2019) 199–210 Contents lists available at ScienceDirect International Journal for Parasitology journal homepage: www.elsevier.com/locate/ijpara Avian malaria on Madagascar: prevalence, biodiversity and specialization of haemosporidian parasites q ⇑ Sandrine Musa a, , Ute Mackenstedt a, Friederike Woog b,1, Anke Dinkel a,1 a University of Hohenheim, Emil-Wolff-Str. 34, 70599 Stuttgart, Germany b State Museum of Natural History Stuttgart, Rosenstein 1, 70191 Stuttgart, Germany article info abstract Article history: Previous studies about geographic patterns of species diversity of avian malaria parasites and others in Received 18 March 2018 the Order Haemosporida did not include the avian biodiversity hotspot Madagascar. Since there are Received in revised form 31 October 2018 few data available on avian malaria parasites on Madagascar, we conducted the first known large- Accepted 1 November 2018 scale molecular-based study to investigate their biodiversity. Samples (1067) from 55 bird species were Available online 22 November 2018 examined by a PCR method amplifying nearly the whole haemosporidian cytochrome b gene (1063 bp). The parasite lineages found were further characterized phylogenetically and the degree of specialization Keywords: was determined with a newly introduced host diversity index (Hd). Our results demonstrate that Plasmodium Madagascar indeed represents a biodiversity hotspot for avian malaria parasites as we detected 71 genet- Haemoproteus Leucocytozoon ically distinct parasite lineages of the genera Plasmodium and Haemoproteus. Furthermore, by using a Host diversity phylogenetic approach and including the sequence divergence we suspect that the detected haemo- sporidian lineages represent at least 29 groups i.e. proposed species. The here presented Hd values for each parasite regarding host species, genus and family strongly support previous works demonstrating the elastic host ranges of some avian parsites of the Order Haemosporida. -
Facilitating the Evolution of Resistance to Avian Malaria in Hawaiian Birds
BIOLOGICAL CONSERVATION 128 (2006) 475– 485 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/biocon Facilitating the evolution of resistance to avian malaria in Hawaiian birds A. Marm Kilpatrick* Department of Zoology, University of Wisconsin-Madison, Madison, WI 53706, United States Consortium for Conservation Medicine, 460 W, 34th Street, 17th Floor, Palisades, NY 10964, United States ARTICLE INFO ABSTRACT Article history: Research has shown that avian malaria plays an important role in limiting the distribution Received 17 February 2005 and population sizes of many Hawaiian birds, and that projected climate change is likely Received in revised form to eliminate most disease-free habitat in Hawai’i in the next century. I used a modeling 2 October 2005 approach, parameterized with demographic data from the literature and the field, to Accepted 10 October 2005 examine alternate management scenarios for the conservation of native Hawaiian birds. Available online 23 November 2005 I examined the feasibility of using management in the form of rodent control to facilitate the evolution of resistance to malaria by increasing the survival and reproduction of native Keywords: birds. Analysis of demographic data from seven native species, Akepa (Loxops coccineus), Management ‘Akohekohe (Palmeria dolei), Elepaio (Chasiempis sandwichensis), Hawai’i’amakihi (Hemigna- Endangered species thus virens), Hawai’i creeper (Oreomystis mana), Omao (Myadestes obscurus), and Palila (Loxio- Drepanidinae ides bailleui), suggest that differences in life history cause some species to be more Rodent control susceptible to local extinctions from the transmission of malaria. Modeling results demon- Demography strated that rodent control at middle, but not high, elevations can facilitate the evolution Survival of resistance to malaria in several species of Hawaiian birds. -
Immunogenetics and Resistance to Avian Malaria in Hawaiian Honeycreepers (Drepanidinae)
Studies in Avian Biology No. 22:254-263, 2001. IMMUNOGENETICS AND RESISTANCE TO AVIAN MALARIA IN HAWAIIAN HONEYCREEPERS (DREPANIDINAE) SUSAN I. JARVI, CARTER T. ATKINSON, AND ROBERT C. FLEISCHER Abstract. Although a number of factors have contributed to the decline and extinction of Hawai‘i’s endemic terrestrial avifauna, introduced avian malaria (Plasmodium relicturn)is probably the single most important factor preventing recovery of these birds in low-elevation habitats. Continued decline in numbers, fragmentation of populations, and extinction of species that are still relatively common will likely continue without new, aggressive approaches to managing avian disease. Methods of in- tervention in the disease cycle such as chemotherapy and vaccine development are not feasible because of efficient immune-evasion strategies evolved by the parasite, technical difficulties associated with treating wild avian populations, and increased risk of selection for more virulent strains of the parasite. We are investigating the natural evolution of disease resistance in some low-elevation native bird populations, particularly Hawai‘i ‘Amakihi (Hemignathus virens), to perfect genetic methods for iden- tifying individuals with a greater immunological capacity to survive malarial infection. We are focusing on genetic analyses of the major histocompatibility complex, due to its critical role in both humoral and cell-mediated immune responses. In the parasite, we are evaluating conserved ribosomal genes as well as variable genes encoding cell-surface molecules as a first step in developing a better under- standing of the complex interactions between malarial parasites and the avian immune system. A goal is to provide population managers with new criteria for maintaining long-term population stability for threatened species through the development of methods for evaluating and maintaining genetic diver- sity in small populations at loci important in immunological responsiveness to pathogens. -
How to Protect Yourself Against Malaria 1 Fig
From our Whitepaper Files: How to > See companion document Protect Yourself Against Malaria World Malaria Risk Chart 2015 Edition Canada 67 Mowat Avenue, Suite 036 Toronto, Ontario M6K 3E3 (416) 652-0137 USA 1623 Military Road, #279 Niagara Falls, New York 14304-1745 (716) 754-4883 New Zealand 206 Papanui Road Christchurch 5 www.iamat.org | [email protected] | Twitter @IAMAT_Travel | Facebook IAMATHealth THE ENEMY area. Of the 460 Anopheles species, approximately 100 can transmit malaria Sunset — the hunt for human blood begins. parasites. From dusk to dawn the female Anopheles, Mosquitoes prey on a variety of hosts — the malaria-carrying mosquito searches for a host humans, monkeys, lizards, birds — carrying to supply her with blood. Blood is an absolute different species of malaria parasites which in necessity for her because it provides the protein turn infect only specific hosts. Of the approxi- needed for the development of her eggs which mately 50 different species of malaria parasites she later deposits in her breeding place. sharing the genetic name Plasmodium, only She has a tiny, elegant body, measuring 5 infect humans: Plasmodium falciparum, from 8 mm to 1 cm. She has dark spots on the killer; Plasmodium vivax; Plasmodium ovale, her wings, three pairs of long, slender legs and Plasmodium malariae and Plasmodium knowlesi. a prominent tubular proboscis with which The latter, a malaria parasite of Old World she draws blood. monkeys, has been identified to infect humans Fig. 1 Female Anopheles mosquito. The Anopheles enters your room at night. in Southeast Asia. In the past this parasite has Image source: World Health Organization You may recognize her by the way she rests been misdiagnosed as Plasmodium malariae. -
A Rapid Field Test for Tolerance to Avian Malaria in Hawaiian Honeycreepers: a New Tool for Restoring Native Hawaiian Forest Birds?
Pacific Islands Climate Change Cooperative A rapid field test for tolerance to avian malaria in Hawaiian honeycreepers: a new tool for restoring native Hawaiian forest birds? Researchers with the US Geological Survey in Researchers evaluated three techniques for Hawai‘i, sponsored by the Pacific Islands their ability to rapidly measure a bird’s Climate Change Cooperative, have determined natural immunity with the hope that such that high levels of natural antibodies could be tests may predict survival from avian malaria. used as a potential marker of resistance to One of the tests yielded results: data showed avian malaria in the ‘Amakihi, a native species that compared to non-infected high-elevation of honeycreeper. This field marker is present birds, low-elevation ‘Amakihi at risk for even in birds who have not been infected. contracting malaria had significantly higher levels of natural antibodies. Avian malaria is a disease introduced into Hawai‘i in the early 1800s, and its rapid Additional work is needed to determine spread has contributed to the extinction of at whether the high levels of natural antibodies least 10 native bird species. Native bird correlate with the ability to recover from populations at cooler, higher elevations have avian malaria in ‘Amakihi and other native been protected from exposure to malaria honeycreepers. The field blood test used is because the mosquitos that spread the disease rapid, works regardless of whether the birds cannot survive there. However, avian malaria are infected with malaria or not, is relatively is likely to spread into Hawai‘i’s highest inexpensive, and works for a wide range of elevation forests as a result of increasing species. -
Drug Resistance in Malaria Eugene Mark Department of Biochemistry University of Ghana
http://www.inosr.net/inosr-scientific-research/ INOSR Scientific Research 4(1): 1-12, 2018. Eugene ©INOSR PUBLICATIONS International Network Organization for Scientific Research ISSN: 2705-1706 Drug Resistance in Malaria Eugene Mark Department of Biochemistry University of Ghana ABSTRACT Drug resistant malaria is primarily caused Established and strong drug pressure by Plasmodium falciparum, a species combined with low antiparasitic immunity highly prevalent in tropical. It causes probably explains the multidrug-resistance severe fever or anaemia that leads to more encountered in the forests of South-east than a million deaths each year. The Asia and South America. In Africa, emergence of chloroquine resistance has frequent genetic recombination in been associated with a dramatic increase Plasmodium originate from a high level of in malaria mortality among inhabitants of malaria transmission, and falciparum some endemic regions. The mechanisms of chloroquine-resistant prevalence seems to resistance for amino-alcohols (quinine, stabilize at the same level as chloroquine- mefloquine and halofantrine) are still sensitive malaria. Nevertheless, resistance unclear. Epidemiological studies have levels may differ according to place and established that the frequency of time. In vivo and in vitro tests do not chloroquine resistant mutants varies provide an adequate accurate map of among isolated parasite populations, while resistance. Biochemical tools at a low cost resistance to antifolates is highly prevalent are urgently needed for prospective in most malarial endemic countries. monitoring of resistance. Keywords: Drug, Resistance, Malaria. INTRODUCTION Malaria is a mosquito-borne infectious reproduce [3]. Five species of Plasmodium disease that affects humans and other can infect and be spread by humans. -
Hydroxychloroquine: a Physiologically-Based Pharmacokinetic Model in the Context of Cancer-Related Autophagy Modulation S
Supplemental material to this article can be found at: http://jpet.aspetjournals.org/content/suppl/2018/02/08/jpet.117.245639.DC1 1521-0103/365/3/447–459$35.00 https://doi.org/10.1124/jpet.117.245639 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 365:447–459, June 2018 Copyright ª 2018 by The American Society for Pharmacology and Experimental Therapeutics Hydroxychloroquine: A Physiologically-Based Pharmacokinetic Model in the Context of Cancer-Related Autophagy Modulation s Keagan P. Collins, Kristen M. Jackson, and Daniel L. Gustafson School of Biomedical Engineering (K.P.C., K.M.J., D.L.G.) and Department of Clinical Sciences (D.L.G.), Colorado State University, Fort Collins, Colorado; and University of Colorado Cancer Center, Aurora, Colorado (D.L.G.) Received October 10, 2017; accepted February 6, 2018 ABSTRACT Downloaded from Hydroxychloroquine (HCQ) is a lysosomotropic autophagy in- adapted to simulate human HCQ exposure in whole blood and hibitor being used in over 50 clinical trials either alone or in urine through allometric scaling and species-specific parameter combination with chemotherapy. Pharmacokinetic (PK) and modification. The human model accurately simulated average pharmacodynamic (PD) studies with HCQ have shown that drug steady-state concentrations (Css) of those observed in five exposure in the blood does not correlate with autophagy different HCQ combination clinical trials across seven different inhibition in either peripheral blood mononuclear cells or tumor doses, which was then expanded by comparison of the Css tissue. To better explain this PK/PD disconnect, a PBPK was distribution in a virtual human population at this range of doses. -
PHARMACOLOGY of NEWER ANTIMALARIAL DRUGS: REVIEW ARTICLE Bhuvaneshwari1, Souri S
REVIEW ARTICLE PHARMACOLOGY OF NEWER ANTIMALARIAL DRUGS: REVIEW ARTICLE Bhuvaneshwari1, Souri S. Kondaveti2 HOW TO CITE THIS ARTICLE: Bhuvaneshwari, Souri S. Kondaveti. ‖Pharmacology of Newer Antimalarial Drugs: Review Article‖. Journal of Evidence based Medicine and Healthcare; Volume 2, Issue 4, January 26, 2015; Page: 431-439. ABSTRACT: Malaria is currently is a major health problem, which has been attributed to wide spread resistance of the anopheles mosquito to the economical insecticides and increasing prevalence of drug resistance to plasmodium falciparum. Newer drugs are needed as there is a continual threat of emergence of resistance to both artemisins and the partner medicines. Newer artemisinin compounds like Artemisone, Artemisnic acid, Sodium artelinate, Arteflene, Synthetic peroxides like arterolane which is a synthetic trioxolane cognener of artemisins, OZ439 a second generation synthetic peroxide are under studies. Newer artemisinin combinations include Arterolane(150mg) + Piperaquine (750mg), DHA (120mg) + Piperaquine(960mg) (1:8), Artesunate + Pyronardine (1:3), Artesunate + Chlorproguanil + Dapsone, Artemisinin (125mg) + Napthoquine (50mg) single dose and Artesunate + Ferroquine.Newer drugs under development including Transmission blocking compounds like Bulaquine, Etaquine, Tafenoquine, which are primaquine congeners, Spiroindalone, Trioxaquine DU 1302, Epoxamicin, Quinolone 3 Di aryl ether. Newer drugs targeting blood & liver stages which include Ferroquine, Albitiazolium – (SAR – 97276). Older drugs with new use in malaria like beta blockers, calcium channel blockers, protease inhibitors, Dihydroorotate dehydrogenase inhibitors, methotrexate, Sevuparin sodium, auranofin, are under preclinical studies which also target blood and liver stages. Antibiotics like Fosmidomycin and Azithromycin in combination with Artesunate, Chloroquine, Clindamycin are also undergoing trials for treatment of malaria. Vaccines - RTS, S– the most effective malarial vaccine tested to date. -
Extinction Patterns in the Avifauna of the Hawaiian Islands
Diversity and Distributions, (Diversity Distrib.) (2008) 14, 509–517 Blackwell Publishing Ltd BIODIVERSITY Extinction patterns in the avifauna of the RESEARCH Hawaiian islands Alison G. Boyer Department of Biology, University of ABSTRACT New Mexico, Albuquerque, New Mexico, 87131 Through the continuing accumulation of fossil evidence, it is clear that the avifauna of the Hawaiian Islands underwent a large-scale extinction event around the time of Polynesian arrival. A second wave of extinctions since European colonization has further altered this unique avifauna. Here I present the first systematic analysis of the factors characterizing the species that went extinct in each time period and those that survived in order to provide a clearer picture of the possible causal mechanisms. These analyses were based on mean body size, dietary and ecological information and phylogenetic lineage of all known indigenous, non-migratory land and freshwater bird species of the five largest Hawaiian Islands. Extinct species were divided into ‘prehistoric’ and ‘historic’ extinction categories based on the timing of their last occurrence. A model of fossil preservation bias was also incorporated. I used regression trees to predict probability of prehistoric and historic extinction based on ecological variables. Prehistoric extinctions showed a strong bias toward larger body sizes and flightless, ground-nesting species, even after accounting for preservation bias. Many small, specialized species, mostly granivores and frugivores, also disappeared, implicating a wide suite of human impacts including destruction of dry forest habitat. In contrast, the highest extinction rates in the historic period were in medium-sized nectarivorous and insectivorous species. These differences result from different causal mechanisms underlying the two waves Correspondence: Alison G. -
Malaria Surveillance — United States, 2017
Morbidity and Mortality Weekly Report Surveillance Summaries / Vol. 70 / No. 2 March 19, 2021 Malaria Surveillance — United States, 2017 U.S. Department of Health and Human Services Centers for Disease Control and Prevention Surveillance Summaries CONTENTS Introduction ............................................................................................................2 Methods ....................................................................................................................4 Results .......................................................................................................................6 Discussion ............................................................................................................. 26 References ............................................................................................................. 32 The MMWR series of publications is published by the Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services, Atlanta, GA 30329-4027. Suggested citation: [Author names; first three, then et al., if more than six.] [Title]. MMWR Surveill Summ 2021;70(No. SS-#):[inclusive page numbers]. Centers for Disease Control and Prevention Rochelle P. Walensky, MD, MPH, Director Anne Schuchat, MD, Principal Deputy Director Daniel B. Jernigan, MD, MPH, Acting Deputy Director for Public Health Science and Surveillance Rebecca Bunnell, PhD, MEd, Director, Office of Science Jennifer Layden, -
Springer MRW: [AU:0, IDX:0]
P Pharmacology of Antimalarial studies were performed by German scientists just Drugs, Current Anti-malarials before World War II. However, the drug was reported to be too toxic for human use and not Kesara Na-Bangchang1 and Juntra Karbwang2 introduced for general use at that time. By late 1Chulabhorn International College of Medicine, 1944, in the intensive search for an effective anti- Thammasat University, Pathumtanee, Thailand malarial drug during World War II, US workers 2Clinical Product Development, Institute of synthesized 25 different 4-aminoquinoline deriv- Tropical Medicine, Nagasaki, Japan atives, with the objective of discovering more effective and less toxic suppressive agents than quinacrine. Of these compounds, chloroquine Currently available antimalarial drugs can be clas- proved the most promising and later underwent sified into four broad categories according to their extensive clinical studies. Since then, chloroquine chemical structures and modes of action. had been used as the drug of choice for treatment of human malaria all over the world until the 1. Arylamino alcohol compounds: quinine, quin- advent of chloroquine resistance in Plasmodium idine, chloroquine, amodiaquine, mefloquine, falciparum in the early 1960s. Clinical treatment halofantrine, piperaquine, and lumefantrine failures of P. falciparum were first noted in 2. 8-Aminoquinoline: primaquine and Thailand almost at the same time as in South tafenoquine America. Chloroquine-resistant P. falciparum 3. Antifolate compounds: sulfadoxine, pyrimeth- has since then spread relentlessly to virtually all amine, proguanil, chlorproguanil, and areas of the world except Central America, North trimethoprim Africa, and parts of Western Asia. 4. Artemisinin compounds: artemisinin, artesunate, artemether, b-arteether, and dihydroartemisinin Chemistry and Physical Properties 5.